A common variant association study in ethnic Saudi Arabs reveals novel susceptibility loci for hypertriglyceridemia

Clinical Genetics

Volumn 91, Issue 3, 2017, Pages 371-378

  Ram, R ^a,b   Wakil, S M ^c   Muiya, N P ^c   Andres, E ^c   Mazhar, N ^c   Hagos, S ^c   Alshahid, M ^c   Meyer, B F ^c   Morahan, G ^a,b   Dzimiri, N ^c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

APOA1 APOA5 gene cluster; common variants association study; GCKR; LAMC1; meta analysis; MLXIPL; TRIB1

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN A5; BINDING PROTEIN; CARBOHYDRATE RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOKINASE; GLUCOKINASE REGULATORY PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LAMININ GAMMA1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; UNCLASSIFIED DRUG; APOA1 PROTEIN, HUMAN; APOA5 PROTEIN, HUMAN; BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; GCKR PROTEIN, HUMAN; LAMININ; MLXIPL PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ETHNICITY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SAUDI ARABIA; SINGLE NUCLEOTIDE POLYMORPHISM; ARAB; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMAN GENOME; PATHOPHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-V; ARABS; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; CORONARY ARTERY DISEASE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; LAMININ; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SAUDI ARABIA;

EID: 85011304360     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12859     Document Type: Article

References (63)

1. Lee HY, Oh BH. Aging and arterial stiffness. Circ J 2010: 74 (11): 2257–2262.
2. Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation 2005: 111 (25): 3481–3488.
3. Hegele RA, Ban MR, Hsueh N et al. A polygenic basis for four classical Fredrickson hyperlipoproteinemia phenotypes that are characterized by hypertriglyceridemia. Hum Mol Genet 2009: 18 (21): 4189–4194.
4. Motazacker MM, Peter J, Treskes M, Shoulders CC, Kuivenhoven JA, Hovingh GK. Evidence of a polygenic origin of extreme high-density lipoprotein cholesterol levels. Arterioscler Thromb Vasc Biol 2013: 33 (7): 1521–1528.
5. Talmud PJ, Futema M, Humphries SE. The genetic architecture of the familial hyperlipidaemia syndromes: rare mutations and common variants in multiple genes. Curr Opin Lipidol 2014: 25 (4): 274–281.
6. Oosterveer DM, Versmissen J, Defesche JC et al. Low-density lipoprotein receptor mutations generate synthetic genome-wide associations. Eur J Hum Genet 2013: 21 (5): 563–566.
7. Futema M, Plagnol V, Li K et al. Whole exome sequencing of familial hypercholesterolaemia patients negative for LDLR/APOB/PCSK9 mutations. J Med Genet 2014: 51 (8): 537–544.
8. Johansen CT, Wang J, Lanktree MB et al. Excess of rare variants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet 2010: 42 (8): 684–687.
9. Do R, Willer CJ, Schmidt EM et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet 2013: 45 (11): 1345–1352.
10. Willer CJ, Schmidt EM, Sengupta S et al. Discovery and refinement of loci associated with lipid levels. Nat Genet 2013: 45 (11): 1274–1283.
11. Johansen CT, Hegele RA. Genetic bases of hypertriglyceridemic phenotypes. Curr Opin Lipidol 2011: 22 (4): 247–253.
12. Waterworth DM, Ricketts SL, Song K et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2010: 30 (11): 2264–2276.
13. De Castro-Oros I, Cenarro A, Tejedor MT et al. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia. Circ Cardiovasc Genet 2014: 7 (6): 814–821.
14. Surendran RP, Visser ME, Heemelaar S et al. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia. J Intern Med 2012: 272 (2): 185–196.
15. Cefalu AB, Noto D, Arpi ML et al. Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. J Clin Endocrinol Metab 2009: 94 (11): 4584–4590.
16. Peterfy M, Ben-Zeev O, Mao HZ et al. Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia. Nat Genet 2007: 39 (12): 1483–1487.
17. Gonzaga-Jauregui C, Mir S, Penney S et al. Whole-exome sequencing reveals GPIHBP1 mutations in infantile colitis with severe hypertriglyceridemia. J Pediatr Gastroenterol Nutr 2014: 59 (1): 17–21.
18. Dussaillant C, Serrano V, Maiz A et al. APOA5 Q97X mutation identified through homozygosity mapping causes severe hypertriglyceridemia in a Chilean consanguineous family. BMC Med Genet 2012: 13: 106.
19. Mendoza-Barbera E, Julve J, Nilsson SK et al. Structural and functional analysis of APOA5 mutations identified in patients with severe hypertriglyceridemia. J Lipid Res 2013: 54 (3): 649–661.
20. Pisciotta L, Fresa R, Bellocchio A et al. Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. Clin Chim Acta 2011: 412 (23–24): 2194–2198.
21. Expert Panel on Detection E and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001: 285 (19): 2486–97.
22. Lee WC. Testing the genetic relation between two individuals using a panel of frequency-unknown single nucleotide polymorphisms. Ann Hum Genet 2003: 67 (Pt 6): 618–619.
23. Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 2010: 26 (17): 2190–2191.
24. Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet 2011: 88 (1): 76–82.
25. Lippert C, Listgarten J, Liu Y, Kadie CM, Davidson RI, Heckerman D. FaST linear mixed models for genome-wide association studies. Nat Methods 2011: 8 (10): 833–835.
26. Widmer C, Lippert C, Weissbrod O et al. Further improvements to linear mixed models for genome-wide association studies. Sci Rep 2014: 4: 6874.
27. Consortium WTCC. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007: 447 (7145): 661–678.
28. Coban N, Onat A, Guclu-Geyik F, Komurcu-Bayrak E, Can G, Erginel-Unaltuna N. Gender-specific associations of the APOA1 -75G>A polymorphism with several metabolic syndrome components in Turkish adults. Clin Chim Acta 2014: 431: 244–249.
29. Hosseini-Esfahani F, Mirmiran P, Daneshpour MS et al. Dietary patterns interact with APOA1/APOC3 polymorphisms to alter the risk of the metabolic syndrome: the Tehran Lipid and Glucose Study. Br J Nutr 2015: 113 (4): 644–653.
30. Hsu MC, Chang CS, Lee KT et al. Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster. Nutr Diabetes 2013: 3: e61.
31. Iqbal R, Jahan N, Sun Y, Xue H. Genetic association of lipid metabolism related SNPs with myocardial infarction in the Pakistani population. Mol Biol Rep 2014: 41 (3): 1545–1552.
32. Nichols WC, Gregg RE, Brewer HB Jr, Benson MD. A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics 1990: 8 (2): 318–323.
33. Soutar AK, Hawkins PN, Vigushin DM et al. Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci USA 1992: 89 (16): 7389–7393.
34. Vigushin DM, Gough J, Allan D et al. Familial nephropathic systemic amyloidosis caused by apolipoprotein AI variant Arg26. Q J Med 1994: 87 (3): 149–154.
35. Nichols WC, Dwulet FE, Liepnieks J, Benson MD. Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun 1988: 156 (2): 762–768.
36. Caussy C, Charriere S, Marcais C et al. An APOA5 3' UTR variant associated with plasma triglycerides triggers APOA5 downregulation by creating a functional miR-485-5p binding site. Am J Hum Genet 2014: 94 (1): 129–134.
37. Chen TZ, Xie SL, Jin R, Huang ZM. A novel lipoprotein lipase gene missense mutation in Chinese patients with severe hypertriglyceridemia and pancreatitis. Lipids Health Dis 2014: 13: 52.
38. Cui G, Li Z, Li R et al. A functional variant in APOA5/A4/C3/A1 gene cluster contributes to elevated triglycerides and severity of CAD by interfering with microRNA 3201 binding efficiency. J Am Coll Cardiol 2014: 64 (3): 267–277.
39. Suarez-Sanchez F, Klunder-Klunder M, Valladares-Salgado A et al. APOA5 and APOA1 polymorphisms are associated with triglyceride levels in Mexican children. Pediat Obes 2016. doi: 10.1111/ijpo.12147.
40. van de Woestijne AP, van der Graaf Y, de Bakker PI, Asselbergs FW, Spiering W, Visseren FL. Rs964184 (APOA5-A4-C3-A1) is related to elevated plasma triglyceride levels, but not to an increased risk for vascular events in patients with clinically manifest vascular disease. PLoS One 2014: 9 (6): e101082.
41. Bi M, Kao WH, Boerwinkle E et al. Association of rs780094 in GCKR with metabolic traits and incident diabetes and cardiovascular disease: the ARIC Study. PLoS One 2010: 5 (7): e11690.
42. Li H, Xu R, Peng X, Wang Y, Wang T. Association of glucokinase regulatory protein polymorphism with type 2 diabetes and fasting plasma glucose: a meta-analysis. Mol Biol Rep 2013: 40 (6): 3935–3942.
43. Murata-Mori F, Hayashida N, Ando T et al. Association of the GCKR rs780094 polymorphism with metabolic traits including carotid intima-media thickness in Japanese community-dwelling men, but not in women. Clin Chem Lab Med 2014: 52 (2): 289–295.
44. Onuma H, Tabara Y, Kawamoto R et al. The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population. J Hum Genet 2010: 55 (9): 600–604.
45. Qi Q, Wu Y, Li H et al. Association of GCKR rs780094, alone or in combination with GCK rs1799884, with type 2 diabetes and related traits in a Han Chinese population. Diabetologia 2009: 52 (5): 834–843.
46. Sparso T, Andersen G, Nielsen T et al. The GCKR rs780094 polymorphism is associated with elevated fasting serum triacylglycerol, reduced fasting and OGTT-related insulinaemia, and reduced risk of type 2 diabetes. Diabetologia 2008: 51 (1): 70–75.
47. Liu Y, Zhou D, Zhang Z et al. Effects of genetic variants on lipid parameters and dyslipidemia in a Chinese population. J Lipid Res 2011: 52 (2): 354–360.
48. Polgar N, Jaromi L, Csongei V et al. Triglyceride level modifying functional variants of GALTN2 and MLXIPL in patients with ischaemic stroke. Eur J Neurol 2010: 17 (8): 1033–1039.
49. Wang J, Ban MR, Zou GY et al. Polygenic determinants of severe hypertriglyceridemia. Hum Mol Genet 2008: 17 (18): 2894–2899.
50. Zeng XN, Yin RX, Huang P et al. Association of the MLXIPL/TBL2 rs17145738 SNP and serum lipid levels in the Guangxi Mulao and Han populations. Lipids Health Dis 2013: 12: 156.
51. Ghasemi A, Aghajani H, Fallah S, Assadi M, Seifi M. C771G (His241Gln) polymorphism of MLXIPL gene, TG levels and coronary artery disease: a case control study. Anadolu Kardiyol Derg 2015: 15 (1): 8–12.
52. Johansen CT, Kathiresan S, Hegele RA. Genetic determinants of plasma triglycerides. J Lipid Res 2011: 52 (2): 189–206.
53. Kathiresan S, Melander O, Guiducci C et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet 2008: 40 (2): 189–197.
54. Radovica I, Fridmanis D, Silamikelis I, Nikitina-Zake L, Klovins J. Association between CETP, MLXIPL, and TOMM40 polymorphisms and serum lipid levels in a Latvian population. Meta Gene 2014: 2: 565–578.
55. Raslova K, Dobiasova M, Hubacek JA et al. Association of metabolic and genetic factors with cholesterol esterification rate in HDL plasma and atherogenic index of plasma in a 40 years old Slovak population. Physiol Res 2011: 60 (5): 785–795.
56. Weissglas-Volkov D, Aguilar-Salinas CA, Nikkola E et al. Genomic study in Mexicans identifies a new locus for triglycerides and refines European lipid loci. J Med Genet 2013: 50 (5): 298–308.
57. Willer CJ, Sanna S, Jackson AU et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008: 40 (2): 161–169.
58. Yang N, Guo S, Zheng F, Gan X, Ning L, Dong S. High plasma fatty acid concentrations were present in non-diabetic patients with coronary heart disease. Clin Lab 2014: 60 (1): 125–131.
59. Douvris A, Soubeyrand S, Naing T et al. Functional analysis of the TRIB1 associated locus linked to plasma triglycerides and coronary artery disease. J Am Heart Assoc 2014: 3 (3): e000884.
60. Walia GK, Gupta V, Aggarwal A et al. Association of common genetic variants with lipid traits in the Indian population. PLoS One 2014: 9 (7): e101688.
61. Pirim D, Wang X, Radwan ZH et al. Lipoprotein lipase gene sequencing and plasma lipid profile. J Lipid Res 2014: 55 (1): 85–93.
62. Wang L, Jing J, Fu Q et al. Association study of genetic variants at newly identified lipid gene TRIB1 with coronary heart disease in Chinese Han population. Lipids Health Dis 2015: 14: 46.
63. De Castro-Oros I, Cenarro A, Tejedor MT et al. Common genetic variants contribute to primary hypertriglyceridemia without differences between familial combined hyperlipidemia and isolated hypertriglyceridemia. Circ Cardiovasc Genet 2014: 7 (6): 814–821.